Impax Asset Management’s Pfizer PFE Stock Holding History

Impax Asset Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-499,132	Closed	-$15.2M	–	201
2014 Q1	$15.2M	Sell	499,132 -104,599	-17%	-$3.12M	0.97%	41
2013 Q4	$17.5M	Buy	603,731 +105,400	+21%	+$3.07M	1.11%	40
2013 Q3	$13.6M	Buy	498,331 +52,487	+12%	+$1.43M	0.9%	48
2013 Q2	$11.8M	Buy	+445,844	New	+$12.3M	0.8%	53

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Impax Asset Management's PFE Position: Q2 2014 in Review

Impax Asset Management sold out of Pfizer (PFE) in Q2 2014, closing a stake of 499,132 shares — an estimated $15.2M sold.

Impax Asset Management first reported a position in PFE in Q2 2013 and held it in 4 quarters. The position peaked at $17.5M in Q4 2013. 1,746 funds tracked by Wall St. Rank hold PFE as of Q2 2014.

Impax Asset Management reported no remaining Pfizer position as of Q2 2014 after selling out during the quarter.
Impax Asset Management sold 499,132 Pfizer shares in Q2 2014, an estimated $15.2M.
Impax Asset Management first reported a position in Pfizer in Q2 2013 and held it in 4 quarters.
Impax Asset Management's Pfizer position peaked at $17.5M in Q4 2013.
1,746 funds tracked by Wall St. Rank held Pfizer as of Q2 2014.

Based on Impax Asset Management's 13F filing for Q2 2014, filed 14 Aug 2014.